Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12544355 | Use of monascinol in preparation of fat-reducing product | 🖼🧊📄§ | 2026-02-10 | 2041-07-09 | 0 | 31 |
| 12545729 | Anti-TREM2 agonist antibodies and antigen-binding fragments thereof that can increase levels of soluble TREM2 in serum and brain tissue | 🖼🧊📄§ | 2026-02-10 | 2045-06-27 | 0 | 31 |
| 12544426 | Combination therapy with CD13-targeted chimeric proteins or chimeric protein complexes | 🖼🧊📄§ | 2026-02-10 | 2040-06-18 | 0 | 31 |
| 12539287 | L-DOPA microbiome therapy | 🖼🧊📄§ | 2026-02-03 | 2043-01-12 | 0 | 31 |
| 12539327 | Norovirus S particle based vaccines and methods of making and using same | 🖼🧊📄§ | 2026-02-03 | 2043-10-19 | 0 | 31 |
| 12540192 | CD20 binding single domain antibodies | 🖼🧊📄§ | 2026-02-03 | 2041-12-21 | 0 | 31 |
| 12539322 | Use of mulberry extract for controlling postprandial glucose response | 🖼🧊📄§ | 2026-02-03 | 2041-04-23 | 0 | 31 |
| 12540185 | Fabs-in-tandem immunoglobulin and uses thereof | 🖼🧊📄§ | 2026-02-03 | 2042-07-12 | 0 | 31 |
| 12539312 | Use of materials made of cross-linked β-cyclodextrins for the treatment of tuberculosis | 🖼🧊📄§ | 2026-02-03 | 2040-02-20 | 0 | 31 |
| 12539335 | Tricyclic polypeptide conjugated drug and use thereof | 🖼🧊📄§ | 2026-02-03 | 2042-09-23 | 0 | 31 |
| 12539273 | External nano liniment for gout and preparation method thereof | 🖼🧊📄§ | 2026-02-03 | 2041-09-22 | 0 | 31 |
| 12539271 | Nanoparticulate compositions | 🖼🧊📄§ | 2026-02-03 | 2042-04-14 | 0 | 31 |
| 12539274 | Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same | 🖼🧊📄§ | 2026-02-03 | 2041-06-10 | 0 | 31 |
| 12539313 | Microbial removal | 🖼🧊📄§ | 2026-02-03 | 2040-03-03 | 0 | 31 |
| 12540139 | Imidazopiperazine inhibitors of transcription activating proteins | 🖼🧊📄§ | 2026-02-03 | 2043-03-13 | 0 | 31 |
| 12539329 | Treatment regimen for the treatment of autoimmune disorders | 🖼🧊📄§ | 2026-02-03 | 2044-03-08 | 0 | 31 |
| 12540166 | BNIP3 peptides for treatment of reperfusion injury | 🖼🧊📄§ | 2026-02-03 | 2040-05-08 | 0 | 31 |
| 12539278 | Nanocomposite particle and uses thereof | 🖼🧊📄§ | 2026-02-03 | 2040-09-01 | 0 | 31 |
| 12540115 | Inhibitors of phospholipid synthesis and methods of use | 🖼🧊📄§ | 2026-02-03 | 2040-08-20 | 0 | 31 |
| 12539305 | Methods of treating cancer with an mTOR inhibitor | 🖼🧊📄§ | 2026-02-03 | 2043-05-25 | 0 | 31 |
| 12539340 | Radioconjugates targeting CD33 in the treatment of cancers | 🖼🧊📄§ | 2026-02-03 | 2042-08-08 | 0 | 31 |
| 12540191 | Engineered immune cells targeting BCMA and their uses thereof | 🖼🧊📄§ | 2026-02-03 | 2043-09-29 | 0 | 31 |
| 12539319 | Lactobacillus delbrueckii subsp. lactis CKDB001 strain, and composition for prevention, amelioration, or treatment of non-alcoholic fatty liver comprising same | 🖼🧊📄§ | 2026-02-03 | 2041-03-23 | 0 | 31 |
| 12539293 | Detecting and treating growth hormone deficiency | 🖼🧊📄§ | 2026-02-03 | 2042-01-24 | 0 | 31 |
| 12540143 | Methods and compositions for targeted protein degradation | 🖼🧊📄§ | 2026-02-03 | 2040-04-08 | 0 | 31 |
| 12540334 | Gene therapy for Alzheimer's disease | 🖼🧊📄§ | 2026-02-03 | 2040-05-21 | 0 | 31 |
| 12540174 | Kits and containers for treating vimentin expressing tumors | 🖼🧊📄§ | 2026-02-03 | 2042-10-07 | 0 | 31 |
| 12540184 | Association of polyclonal antibodies and anti-PD1 or anti-PDL1 antibodies for the treatment of cancer | 🖼🧊📄§ | 2026-02-03 | 2040-04-28 | 0 | 31 |
| 12540181 | Anti-CD19/anti-CD3 bispecific antibody, T cells secreting the same, method of preparation and use thereof | 🖼🧊📄§ | 2026-02-03 | 2041-02-16 | 0 | 31 |
| 12538934 | Polyhalite enriched fish feed | 🖼🧊📄§ | 2026-02-03 | 2042-04-01 | 0 | 31 |
| 12540323 | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | 🖼🧊📄§ | 2026-02-03 | 2040-05-21 | 0 | 31 |
| 12539317 | Gene expression system for probiotic microorganisms | 🖼🧊📄§ | 2026-02-03 | 2044-03-26 | 0 | 31 |
| 12539297 | Composition for inhibiting cancer metastasis and treating cancer | 🖼🧊📄§ | 2026-02-03 | 2042-05-11 | 0 | 31 |
| 12540168 | Human amylin analog polypeptides and methods of use | 🖼🧊📄§ | 2026-02-03 | 2044-05-10 | 0 | 31 |
| 12539323 | Anti-psychotic composition and treatment methods | 🖼🧊📄§ | 2026-02-03 | 2041-12-01 | 0 | 31 |
| 12540164 | Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis | 🖼🧊📄§ | 2026-02-03 | 2042-12-19 | 0 | 31 |
| 12539284 | Aminoxy acid-based anti-cancer stem cell compounds and methods thereof | 🖼🧊📄§ | 2026-02-03 | 2040-11-23 | 0 | 31 |
| 12540186 | Anti-EGFRvIII antibodies and antigen-binding fragments thereof | 🖼🧊📄§ | 2026-02-03 | 2040-03-23 | 0 | 31 |
| 12539303 | RET inhibitor for use in treating cancer having a RET alteration | 🖼🧊📄§ | 2026-02-03 | 2044-03-15 | 0 | 31 |
| 12539286 | Compositions of β-aminoisobutyric acid and methods for use thereof | 🖼🧊📄§ | 2026-02-03 | 2043-06-27 | 0 | 31 |
| 12539310 | Hetero-structured ribonucleic acid and use thereof | 🖼🧊📄§ | 2026-02-03 | 2041-10-26 | 0 | 31 |
| 12539264 | Composition comprising pentapeptide as active ingredient | 🖼🧊📄§ | 2026-02-03 | 2041-06-11 | 0 | 31 |
| 12540173 | Methods of treating cancer by targeting ZSCAN4 activity in cancer stem cells | 🖼🧊📄§ | 2026-02-03 | 2040-05-22 | 0 | 31 |
| RE050776 | Inhibitors of cyclin-dependent kinases | 🖼🧊📄§ | 2026-02-03 | 2043-03-09 | 0 | 31 |
| 12540175 | Anti-ApoE antibodies | 🖼🧊📄§ | 2026-02-03 | 2044-02-08 | 0 | 31 |
| 12539301 | Compound external preparation for treating alopecia areata and preparation method therefor | 🖼🧊📄§ | 2026-02-03 | 2041-11-11 | 0 | 31 |
| 12539304 | Combination of an anaplastic lymphoma kinase inhibitor and a cyclin dependent kinase inhibitor | 🖼🧊📄§ | 2026-02-03 | 2041-03-02 | 0 | 31 |
| 12540133 | Potent and selective compounds as serotonin 1B receptor modulators | 🖼🧊📄§ | 2026-02-03 | 2041-10-07 | 0 | 31 |
| 12539298 | Lobinaline N-oxides as positive allosteric modulators of the dopamine transporter with potential value in the treatment of substance abuse disorders | 🖼🧊📄§ | 2026-02-03 | 2040-11-25 | 0 | 31 |
| 12539326 | Methods for treating Alzheimer's disease using semaglutide | 🖼🧊📄§ | 2026-02-03 | 2044-12-12 | 0 | 31 |